BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17873031)

  • 1. Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.
    Bröms JE; Francis MS; Forsberg A
    J Bacteriol; 2007 Dec; 189(23):8417-29. PubMed ID: 17873031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Amino-Terminal Part of the Needle-Tip Translocator LcrV of
    Ekestubbe S; Bröms JE; Edgren T; Fällman M; Francis MS; Forsberg Å
    Front Cell Infect Microbiol; 2016; 6():175. PubMed ID: 27995096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation.
    Pettersson J; Holmström A; Hill J; Leary S; Frithz-Lindsten E; von Euler-Matell A; Carlsson E; Titball R; Forsberg A; Wolf-Watz H
    Mol Microbiol; 1999 Jun; 32(5):961-76. PubMed ID: 10361299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LcrV synthesis is altered by DNA adenine methylase overproduction in Yersinia pseudotuberculosis and is required to confer immunity in vaccinated hosts.
    Badie G; Heithoff DM; Mahan MJ
    Infect Immun; 2004 Nov; 72(11):6707-10. PubMed ID: 15501808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of type III effector translocation by Yersinia pseudotuberculosis expressing native LcrV or PcrV from Pseudomonas aeruginosa.
    Bröms JE; Sundin C; Francis MS; Forsberg A
    J Infect Dis; 2003 Jul; 188(2):239-49. PubMed ID: 12854079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica.
    DeBord KL; Lee VT; Schneewind O
    J Bacteriol; 2001 Aug; 183(15):4588-98. PubMed ID: 11443094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
    Harmon DE; Murphy JL; Davis AJ; Mecsas J
    J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III secretion translocon assemblies that attenuate Yersinia virulence.
    Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
    Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG.
    Nilles ML; Fields KA; Straley SC
    J Bacteriol; 1998 Jul; 180(13):3410-20. PubMed ID: 9642196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis.
    Costa TR; Edqvist PJ; Bröms JE; Ahlund MK; Forsberg A; Francis MS
    J Biol Chem; 2010 Aug; 285(33):25269-84. PubMed ID: 20525687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.
    Sing A; Reithmeier-Rost D; Granfors K; Hill J; Roggenkamp A; Heesemann J
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16049-54. PubMed ID: 16239347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.
    Håkansson S; Schesser K; Persson C; Galyov EE; Rosqvist R; Homblé F; Wolf-Watz H
    EMBO J; 1996 Nov; 15(21):5812-23. PubMed ID: 8918459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimolecular fluorescence complementation assay to explore protein-protein interactions of the Yersinia virulence factor YopM.
    Uğurlu Ö; Evran S
    Biochem Biophys Res Commun; 2021 Dec; 582():43-48. PubMed ID: 34689104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia pestis LcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response.
    Nilles ML; Williams AW; Skrzypek E; Straley SC
    J Bacteriol; 1997 Feb; 179(4):1307-16. PubMed ID: 9023216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two substrate-targeting sites in the Yersinia protein tyrosine phosphatase co-operate to promote bacterial virulence.
    Ivanov MI; Stuckey JA; Schubert HL; Saper MA; Bliska JB
    Mol Microbiol; 2005 Mar; 55(5):1346-56. PubMed ID: 15720545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative study of the role of the yadA, invA, and psaA genes in the pathogenicity of Yersinia pseudotuberculosis].
    Karataev GI; Markov AR; Siniashina LN; Miller GG; Klitsunova NV; Titova IV; Semin EG; Goncharova NI; Pokrovskaia MS; Amelina IP; Amoako K; Smirnov GB
    Mol Gen Mikrobiol Virusol; 2008; (4):10-8. PubMed ID: 19172873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis.
    Pouliot K; Pan N; Wang S; Lu S; Lien E; Goguen JD
    Infect Immun; 2007 Jul; 75(7):3571-80. PubMed ID: 17438030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.